ApiFix Signs Canada Distribution Agreement
ApiFix granted exclusive distribution rights to Joint Solutions Alliance for its scoliosis treatment in Canada. Sep 05, 2017
Bioventus Receives FDA Premarket Approval for DUROLANE
Bioventus received FDA premarket approval for DUROLANE single-injection hyaluronic acid to treat pain associated with knee osteoarthritis. Sep 05, 2017
CollPlant Negotiating Private Placement of $5MM
CollPlant is in advanced negotiations with a U.S. investor for a US $5.0MM private placement. Sep 05, 2017
Orthocell Recruits First Patient for Ortho-ATI Shoulder Tendon Study
Orthocell announced recruitment of the first patient in a clinical trial investigating Ortho-ATI® to treat rotator cuff tendinopathy. Sep 05, 2017
David Demski Appointed Globus Medical CEO
Globus Medical’s board has named David Demski as Chief Executive Officer, effective immediately. Aug 30, 2017
Mazor Robotics and Medtronic Enter Next Phase of Strategic Partnership
Mazor Robotics entered Phase II of its strategic partnership with Medtronic, which will now take on exclusive global distribution of the Mazor X surgical assistance platform. Aug 30, 2017
MicroPort Orthopedics Launches Procotyl Prime Acetabular Cup
MicroPort Orthopedics launched the Procotyl® Prime acetabular cup, the next step in the evolution of its Dynasty® Acetabular Cup System. Aug 29, 2017
OrthoPediatrics and Mighty Oak Medical Partner on Spinal Navigation
OrthoPediatrics entered into an agreement for exclusive U.S. distribution of Mighty Oak Medical’s FIREFLY® pedicle screw navigation guides in pediatric hospitals. Aug 29, 2017
Orthopaedic Supplier M&A Boosted by Private Equity Backing
Supplier companies have been involved in 17 of the 33 mergers and acquisitions that have closed in the orthopaedic space as of August 15, according to our tracking of activity. This activity comes in direct response to device company consolidation. Aug 29, 2017
Regentis Biomaterials Receives CE Mark Approval for GelrinC Implant
Regentis Biomaterials received CE Mark approval for a GelrinC biodegradable implant based on denatured human fibrinogen for the treatment of articular knee cartilage defects. Aug 28, 2017
